Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Badger Meter
BMI
$3.91B
| $13.4M | 0.02% |
87,000
+6,600
| +8% | +$961K |
|
802
Air Products & Chemicals
APD
$67.7B
| $13.3M | 0.02% |
+48,700
| New | +$13.4M |
|
|
ELME
803
Elme Communities
ELME
$144M
| $13.3M | 0.02% |
913,008
+279,300
| +44% | +$3.82M |
|
804
Parker-Hannifin
PH
$135B
| $13.3M | 0.02% |
28,850
-36,600
| -56% | -$15.2M |
|
805
PubMatic
PUBM
$783M
| $13.3M | 0.02% |
814,800
+43,600
| +6% | +$632K |
|
|
SVM
806
Silvercorp Metals
SVM
$2.68B
| $13.3M | 0.02% |
5,052,896
-221,200
| -4% | -$542K |
|
807
WisdomTree
WT
$3.44B
| $13.3M | 0.02% |
1,915,879
+777,900
| +68% | +$5.15M |
|
808
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $13.2M | 0.02% |
+521,700
| New | +$12.7M |
|
809
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $13.2M | 0.02% |
226,062
+121,062
| +115% | +$7M |
|
810
Glaukos
GKOS
$11.2B
| $13.2M | 0.02% |
165,692
+122,200
| +281% | +$8.33M |
|
|
SFIX
811
Stitch Fix
SFIX
$474M
| $13.2M | 0.02% |
3,687,517
+917,009
| +33% | +$3.24M |
|
812
Olin
OLN
$2.13B
| $13.2M | 0.02% |
243,800
-207,900
| -46% | -$9.95M |
|
813
Civeo
CVEO
$345M
| $13.1M | 0.02% |
572,681
+5,333
| +0.9% | +$115K |
|
814
Merck
MRK
$328B
| $13.1M | 0.02% |
119,824
-247,819
| -67% | -$25.7M |
|
815
TORM
TRMD
$2.97B
| $13M | 0.02% |
428,600
-55,603
| -11% | -$1.64M |
|
816
Pilgrim's Pride
PPC
$6.4B
| $13M | 0.02% |
471,113
+56,300
| +14% | +$1.43M |
|
817
Vir Biotechnology
VIR
$1.52B
| $13M | 0.02% |
1,294,600
-59,800
| -4% | -$546K |
|
818
Credo Technology Group
CRDO
$50B
| $13M | 0.02% |
667,037
-53,601
| -7% | -$911K |
|
819
Quanterix
QTRX
$139M
| $13M | 0.02% |
474,700
+154,900
| +48% | +$3.65M |
|
820
AngloGold Ashanti
AU
$48.1B
| $13M | 0.02% |
693,616
-711,684
| -51% | -$12.8M |
|
821
Nathan's Famous
NATH
$397M
| $13M | 0.02% |
166,049
-2,507
| -1% | -$172K |
|
822
Safety Insurance
SAFT
$1.52B
| $12.9M | 0.02% |
170,300
-29,300
| -15% | -$2.21M |
|
|
MODV
823
DELISTED
ModivCare
MODV
| $12.9M | 0.02% |
294,099
-61,700
| -17% | -$2.44M |
|
824
The RMR Group
RMR
$337M
| $12.9M | 0.02% |
456,414
+18,400
| +4% | +$449K |
|
825
Abercrombie & Fitch
ANF
$4.99B
| $12.9M | 0.02% |
146,000
-282,531
| -66% | -$20.1M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.